Recruiting

i-Lumen AMDMicrocurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

Sponsor:

i-Lumen Scientific AUS PTY LTD

Code:

NCT06662162

Conditions

Age-Related Macular Degeneration

Age-related Macular Degeneration (ARMD)

Intermediate AMD

Geographic Atrophy Secondary to Age-related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

i-Lumen AMD

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-27. This information was provided to ClinicalTrials.gov by i-Lumen Scientific AUS PTY LTD on 2026-08-26.